Pharmagen, Inc.
PHRX
$0.00
$0.000.00%
OTC PK
| 03/31/2014 | 12/31/2013 | 09/30/2013 | 06/30/2013 | 03/31/2013 | |
|---|---|---|---|---|---|
| Net Income | 15.35% | -152.14% | -29.87% | -216.58% | -145.21% |
| Total Depreciation and Amortization | 62.37% | 325.32% | 178.13% | 325.00% | 75.47% |
| Total Amortization of Deferred Charges | -6.58% | 68.39% | 1,557.81% | 411.61% | 4,763.03% |
| Total Other Non-Cash Items | -167.80% | 264.20% | -105.69% | 417.56% | -211.28% |
| Change in Net Operating Assets | 150.67% | 988.69% | -22.68% | 101.19% | 226.84% |
| Cash from Operations | 130.14% | 95.85% | -186.83% | 68.19% | 57.07% |
| Capital Expenditure | -281.60% | -504.17% | 80.46% | 91.83% | -270.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -281.60% | 65.80% | 80.46% | 91.83% | -270.45% |
| Total Debt Issued | -- | -100.00% | 126.00% | -84.78% | 39.80% |
| Total Debt Repaid | -112.05% | 51.47% | -- | -1,306.50% | -12.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -89.53% | -91.29% | 270.73% | -105.23% | 31.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.07% | -86.47% | -146.39% | -1,298.42% | 21,526.67% |